Enhancing antitumor efficacy of nucleoside analog 5-fluorodeoxyuridine on her2-overexpressing breast cancer by affibody-engineered DNA nanoparticle

Medicine & Life Sciences

• Floxuridine 80%
• Nucleosides 56%
• Nanoparticles 47%
• Breast Neoplasms 34%
• Nanostructures 31%
• DNA 29%
• Solid-Phase Synthesis Techniques 7%
• FITC-annexin A5 5%
• Pharmaceutical Preparations 5%
• Blood Circulation 5%
• MCF-7 Cells 4%
• Adjuvant Chemotherapy 4%
• Fluorescence Microscopy 4%
• Antineoplastic Agents 4%
• Confocal Microscopy 4%
• Drug Resistance 4%
• In Vitro Techniques 3%
• Therapeutic Uses 3%
• Flow Cytometry 3%
• Monoclonal Antibodies 3%
• Staining and Labeling 2%
• Neoplasms 2%
• Apoptosis 2%
• Therapeutics 2%

Engineering & Materials Science

• Nucleosides 100%
• DNA 55%
• Nanoparticles 52%
• Nanostructures 32%
• Molecules 8%
• Targeted drug delivery 7%
• Monoclonal antibodies 6%
• Chemotherapy 6%
• Flow cytometry 6%
• Cell death 6%
• Cytotoxicity 6%
• Confocal microscopy 6%
• Fluorescence microscopy 6%
• Biocompatibility 5%
• Hemodynamics 5%
• Molar ratio 5%
• Toxicity 5%
• Assays 5%
• Tumors 4%
• Cells 4%

Chemical Compounds

• Nucleoside Analogue 64%
• Antitumor 49%
• Nanomaterial 33%
• Nanoparticle 26%
• Adjuvant 22%
• Nanocarrier 19%
• Antineoplastic Agent 15%
• Cytometry 9%
• Fluorescence Microscopy 8%
• Tetrahedral Crystal 8%
• Nucleoside 8%
• Molecule 6%
• Flow 5%
• Drug 4%
• Application 2%